Apnea Hypopnea Index Severity Versus Head Position During Sleep

Status Completed

Clinical Trial Summary

This study evaluates the correlation of the position of the head during sleep, independent of the position of the torso, and the severity of apnea hypopneas in obstructive sleep apnea.

Clinical Trial Description

Obstructive Sleep Apnea (OSA) is a common diagnosis in the general population, with a prevalence in the United States of 3-7% in men and 2-5% in women. It is defined as a sleep-related breathing disorder that results in decreased or complete cessation of airflow while the patient has ongoing breathing effort.

It is well documented that trunk position significantly affects the severity of OSA. In fact, 50-75% of individuals with a diagnosis of OSA show supine predominance or worsened apnea-hypopnea index (AHI) when sleeping in the supine position. Positional Obstructive Sleep Apnea (POSA) is defined as an AHI ≥5 with >50% AHI reduction between the supine and non-supine positions and AHI. Studies show 49.5% of individuals with mild OSA (AHI 5-15), 19.4% with moderate OSA (AHI 15-30) and 6.5% in severe OSA (AHI > 30) had POSA. Due to this high prevalence of POSA, especially in the mild and moderate OSA populations, positional therapies have been developed and researched.

In this clinical trial, if only the head position is considered, all subjects are positional sensitive and OSA severity can be calculated and consistently minimized by limiting the allowable range of head roll angle during sleep. Ten subjects underwent a standard polysomnography with an additional head angle sensor and coached to fall asleep in various head positions. Torso position was changed between supine and non-supine for a given head roll angle epoch to show the OSA severity change with torso position. Each sleep epoch of unique head pitch and roll angle was scored individually for AHI and Oxygen Saturation (SPO2) de-saturation.

Investigators hypothesize that specific head roll angles independent of torso position will significantly reduce AHI and SpO2 desaturation severity in patients. The primary aim is to determine the head roll angles that significantly improve POSA independent of torso position. By doing this, Investigators believe to identify a "safe zone" of head roll angles that improve POSA and that can be used to support the development of head positional therapy for POSA patients. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04086407
Study type	Interventional
Source	Sleep Systems
Contact
Status	Completed
Phase	N/A
Start date	November 28, 2016
Completion date	November 30, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05582070` - Effect on Sleep of Surgical Treatment of Severe Nasal Obstruction	N/A
Recruiting	`NCT03919955` - A Novel Pharmacological Therapy for Obstructive Sleep Apnea	Phase 2
Completed	`NCT03927547` - Sleep Disordered Breathing and Cardiopulmonary Disease in Peruvian Highlanders	N/A
Recruiting	`NCT04007380` - Psychosocial, Cognitive, and Behavioral Consequences of Sleep-disordered Breathing After SCI	N/A
Completed	`NCT02188498` - Electrocardiography Data Analysis in Sleep Disorders
Completed	`NCT01503164` - Effects of Continuous Positive Airway Pressure (CPAP) on Glucose Metabolism	N/A
Recruiting	`NCT00747890` - Surgical Treatment of Mild Obstructive Sleep Apnea	N/A
Active, not recruiting	`NCT00738179` - Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea to Prevent Cardiovascular Disease	Phase 3
Completed	`NCT00841906` - Alice PDx User/Validation Extended Trial	N/A
Completed	`NCT00202501` - Usefulness of Nasal Continuous Positive Airway Pressure (CPAP) Treatment in Patients With a First Ever Stroke and Sleep Apnea Syndrome	N/A
Completed	`NCT00047463` - Effects of Treating Obstructive Sleep Apnea in Epilepsy	Phase 2
Not yet recruiting	`NCT06029881` - Portable System for Non-intrusive Monitoring of Sleep
Recruiting	`NCT06093347` - Central Apnoea Monitor Study
Terminated	`NCT05445869` - Severe OSA Study (SOS)	N/A
Withdrawn	`NCT04096261` - The Importance of Sleep Quality and the Blood-brain Barrier in Cognitive Disorders and Alzheimer's Disease
Recruiting	`NCT04575740` - Phenotyping Mechanistic Pathways for Adverse Health Outcomes in Sleep Apnea	N/A
Completed	`NCT04676191` - Validation of a Contactless Vital Signs Measurement Sensor	N/A
Recruiting	`NCT06015620` - Comorbidities Resolution After MGB Surgery and Change in Body Composition
Completed	`NCT06051097` - Metabolic Syndrome and Obstructive Sleep Apnea
Recruiting	`NCT05687097` - Untreated Sleep Apnea as an Aggravating Factor for Other Secondary Medical Conditions After Spinal Cord Injury

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.